The Albus is a program whose aim is to foster the creation of a scientific network and to increase the knowledge in the use of albumin as a therapeutic product. By supporting this program Grifols demonstrates its commitment to innovation in this field. We consider the program to be a tangible contribution to the improvement of standards and benefits for the patient care.
Application process for the ALBUS Awards Program 2023 is closed.
The awardees will be announced in October 2023.
To see the 2022 ALBUS Award winners please click here.